Melissa Johnson, MD

Melissa Johnson, M.D., is a board-certified medical oncologist and the director of lung cancer research at Sarah Cannon Research Institute. As director of lung cancer research, Dr. Johnson leads the lung cancer clinical trial portfolio across the Sarah Cannon research network. In her role, Dr. Johnson focuses on early phase drug development and leads the solid tumor immune effector cellular therapy program at Sarah Cannon. She also currently serves as the chair of the Cancer Committee at TriStar